Phase 2 Immune-related Adverse Event Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
MelanomaImmune Checkpoint InhibitorImmune-related Adverse Event
Sun Yat-sen University55 enrolled2 locationsNCT07644897
Recruiting
Phase 2
Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis
PneumonitisImmune-related Adverse Event
AHS Cancer Control Alberta94 enrolled1 locationNCT06860542
Recruiting
Phase 2
Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
Immune-related Adverse EventInflammatory Arthritis
Tom Appleton30 enrolled1 locationNCT06037811
Recruiting
Phase 2
Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
Advanced MelanomaDiarrheaImmune-related Adverse Event+1 more
AHS Cancer Control Alberta20 enrolled1 locationNCT05663775
Recruiting
Phase 1Phase 2
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
MalignancyImmune-related Adverse Events
Brigham and Women's Hospital100 enrolled2 locationsNCT06789601
Recruiting
Phase 2
SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)
Mmr DeficiencyImmune-related Adverse EventEndometrial Cancer Stage I+1 more
Queensland Centre for Gynaecological Cancer10 enrolled3 locationsNCT06278857